antibody contract manufacturing service · 2017. 7. 21. · highest quality antibodies we offer a...
TRANSCRIPT
• Preferred partner for the world’s leading IVD manufacturers
• Over 30 years of monoclonal antibody expertise
• Superior outsourcing option - cost-effective, flexible
• Outsource all or just parts of the manufacturing process
That’s what we call the MedixMAB Manufacturing advantage.
ANTIBODY CONTRACT MANUFACTURING SERVICE
www.medixbiochemica.com
Outsourcing is an efficient and economical solution for antibody and antigen manufacturing. At Medix Biochemica, we have developed a streamlined process for in vitro production of monoclonal antibodies and recombinant antigens using bioreactors, fermentation and hollow fiber technology.
As a world leader in MAB manufacturing, we can work with you on all or just parts of your manufacturing process. Our offering covers basic specification-based manufacturing through to management of the entire process, all at the scale and to the deadlines that you need.
HIGHEST QUALITY ANTIBODIES We offer a highly cost-effective service for in vitro monoclonal antibody and recombinant antigen production. Our customised turnkey contract manufacturing service makes antibody and antigen production both effortless and worry-free, with our fully certified quality control system.
Our customised contract manufacturing service conforms to certified quality control systems
• ISO 9001, ISO 13485 and FDA QSR • Serum and protein free culture
media• In vitro production with uniform
product quality from batch to batch
FLEXIBLE OUTSOURCING – PERSONALISED SERVICE
DEPENDABLE CONTRACT MANUFACTURINGWith Medix Biochemica, you get full consultation and support at every stage as standard, and with a dedicated project manager – we’re here to make your life easier!
• Fast and reliable deliveries• Expert customer service and
technical support• Consistent and high quality results• Highly cost-effective
Original
Improved
mg/day total yield mg
6000
5000
4000
3000
2000
1000
0
5500
480109
13
IMPROVEMENT OF HYBRIDOMA CELL LINE DURING PRODUCTION OPTIMISATION
Production system: in vitro hollow fiber bioreactor
Original clone: production 45 days, yield: 480 mg
Improved clone:production 50 days, yield: 5500 mg
10X IMPROVEMENT
EXPERIENCETHE BEST IN MABMANUFACTURING– contact us to find
out more!
• Adaptation to serum & protein free media
• Mycoplasma testing
• Production optimisation
ADAPTATION & OPTIMISATION
PRODUCTION
• Spinner, wave tank & hollow fiber methods
• Scale mg–kg
• Customised methods available
PURIFICATION
• Affinity purification
• Protein A/G chromatography
• Validation lots
QUALITY CONTROL & STORAGE
• Immunoreactivity testing, OD 280, IEF, HPLC-SEC, CE
• Reference stock
• Master and working cell banks
MedixMAB in vitro
CONTRACT MANUFACTURING SERVICE:
To find out how the MedixMAB Manufacturing advantage can enhance your IVD production, get in touch today.
Medix BiochemicaKlovinpellontie 3, FI-02180 Espoo, [email protected]
CONTACT US
Copyright © 08/2016 Medix Biochemica. All rights reserved. Actim and MedixMAB are trademarks or registered trademarks of Medix Biochemica. Medix Biochemica reserves the right to make changes and improvements to any of the products described in this document without prior notice.
www.medixbiochemica.com